Corporate Events

Teijin Limited provided dividend guidance for the first half and fiscal year ending March 31, 2027. For the first half, the company expects to pay a dividend of JPY 25.00 per share, compared to JPY 25.00 per share paid a year ago. For the year, the company expects to pay a dividend of JPY 25.00 per share, compared to JPY 25.00 per share paid a year ago.

Teijin Limited revised consolidated earnings guidance for the fiscal year ending March 31, 2027. For the year, the company expects revenue of JPY 900,000 million, adjusted operating income of JPY 30,000 million, profit attributable to owners of JPY 45,000 million, and basic earnings per share of JPY 233.26.

Teijin Limited, ¥ 25.0, Cash Dividend, Sep-29-2026

Teijin Limited, Q1 2027 Earnings Call, Aug 04, 2026

DuPont de Nemours, Inc. (NYSE:DD) entered into agreement to acquire 50% stake in Dupont Teijin Advanced Papers (Asia) Limited and Dupont Teijin Advanced Papers (Japan) Ltd. from Teijin Limited (TSE:3401) on August 29, 2025. Completion of the share transfer is expected to be delayed into the fiscal year ending March 2027 and completion is scheduled for April 1, 2026. For the period ending December 31, 2024, Dupont Teijin Advanced Papers (Asia) Limited and Dupont Teijin Advanced Papers (Japan) Ltd. reported total revenue of ¥34.08 billion, EBIT of ¥11.34 billion and net income of ¥10.46 billion. As of December 31, 2024, Dupont Teijin Advanced Papers (Asia) Limited and Dupont Teijin Advanced Papers (Japan) Ltd. reported total assets of ¥18.87 billion and total common equity of ¥15.54 billion. The expected completion of the transaction is February 1, 2026 to February 28, 2026. Randy Laxer of Morrison & Foerster LLP (Japan) acted as legal advisor to Teijin Limited (TSE:3401). DuPont de Nemours, Inc. (NYSE:DD) completed the acquisition of 50% stake in Dupont Teijin Advanced Papers (Asia) Limited and Dupont Teijin Advanced Papers (Japan) Ltd. from Teijin Limited (TSE:3401) on April 1, 2026.

Teijin Limited, Board Meeting, Jun 19, 2026. Agenda: To consider and approve the Notice Concerning the Disposal of Treasury Shares as Restricted Stock and Performance Share Units.

Teijin Limited announced that they will report Q1, 2027 results on Aug 04, 2026

Teijin Limited expected to report Q1 2027 results on August 4, 2026. This event was calculated by S&P Global (Created on May 13, 2026).

Teijin Limited reported earnings results for the full year ended March 31, 2026. For the full year, the company reported sales was JPY 873,190 million compared to JPY 1,005,471 million a year ago. Net loss was JPY 88,003 million compared to net income of JPY 28,347 million a year ago. Basic loss per share from continuing operations was JPY 456.33. Diluted loss per share from continuing operations was JPY 456.33. Basic loss per share was JPY 456.33 compared to basic earnings per share of JPY 147.15 a year ago. Diluted loss per share was JPY 456.33 compared to diluted earnings per share of JPY 147.15 a year ago.

Teijin Limited, Annual General Meeting, Jun 19, 2026, at 10:00 Tokyo Standard Time. Location: The Westin Osaka, 2nd Floor, Rose Room, 1-20, Oyodonaka 1-chome, Kita-ku, Osaka-city, Osaka, Japan Osaka Japan Agenda: To consider the business report, consolidated financial statements, non-consolidated financial statements and the report on the results of the audit of consolidated financial statements by the accounting auditor and the audit & supervisory committee for the 160th fiscal year (April 1, 2025 to March 31, 2026); to consider election of six directors excluding directors who are audit & supervisory committee members; to consider election of one director who is an audit & supervisory committee member; and any other matters with the permission of Chairman.

Teijin Limited, 2026 Earnings Call, May 11, 2026

MANAC Chemical Partners Co.,Ltd (TSE:4360) agreed to acquire 99.90% stake in Kinkai Chemicals Co.,Ltd. from Teijin Limited (TSE:3401) on October 30, 2025. As part of acquisition, 164,840 shares will be acquired. For the period ending March 31, 2025, Kinkai Chemicals Co.,Ltd. reported net sales of ¥691 million and operating income of ¥55 million. As of March 31, 2025, Kinkai Chemicals Co.,Ltd. reported total assets of ¥1.15 billion and net assets of ¥863 million. The expected completion of the transaction is March 31, 2026. MANAC Chemical Partners Co.,Ltd (TSE:4360) completed the acquisition of 99.90% stake in Kinkai Chemicals Co.,Ltd. from Teijin Limited (TSE:3401) on March 31, 2026.

Teijin Limited revised consolidated earnings guidance for the fiscal year ending March 31, 2026. For the year, the company expected revenue of JPY 860,000 million compared to previous guidance of JPY 860,000 million a year ago, Operating loss in range of JPY 75,000 million - JPY 85,000 million compared to previous guidance of Operating income of JPY 5,000 million. Loss attributable to owners of parent range of JPY 85,000 million - JPY 95,000 million as compared to previous loss guidance of JPY 10,000 million. Basic loss per share of JPY JPY 440.76 - JPY 492.62 compared to previous loss guidance of JPY 51.85. Reasons for revision of earnings forecasts: As announced in the Notice of Change in Equity Method Affiliates (Share Transfer) dated August 29, 2025, Teijin Limited resolved to transfer its shares in DuPont Teijin Advanced Papers (Japan) Limited and DuPont Teijin Advanced Papers (Asia) Limited. However, Completion of the share transfer is expected to be delayed into the fiscal year ending March 2027 (completion is scheduled for April 1, 2026). In addition, the Company is considering selectively narrowing the portfolio of its pharmaceutical business, aside from the rare/intractable disease areas that it focuses on, to fundamentally improve its profitability. As part of this measure, Teijin Pharma Limited, a consolidated subsidiary of the Company, reevaluated the recoverable amount of the sales rights for diabetes treatments, and concluded that there was a high likelihood of an impairment loss being recorded. Furthermore, in light of the above, Teijin Limited and Teijin Pharma Limited reassessed the recoverability of deferred tax assets, concluding that the likelihood of needing to write down a part of the deferred tax assets has increased.

Teijin Limited announced that they will report fiscal year 2026 results on May 11, 2026

Teijin Limited provided consolidated earnings guidance for the fiscal year ending March 31, 2026. For the year, the company expects revenue of JPY 860,000 million, Operating income of JPY 5,000 million, Loss attributable to owners of parent of JPY 10,000 million. Loss earnings per share of JPY 51.85.

Teijin Limited reported earnings results for the nine months ended December 31, 2025. For the nine months, the company reported sales was JPY 659,878 million compared to JPY 756,112 million a year ago. Net loss was JPY 58,970 million compared to net income of JPY 50,980 million a year ago. Basic loss per share from continuing operations was JPY 305.81. Diluted loss per share from continuing operations was JPY 305.81. Basic loss per share was JPY 305.81 compared to basic earnings per share of JPY 264.66 a year ago. Diluted loss per share was JPY 305.81 compared to diluted earnings per share of JPY 264.66 a year ago.

New Business Development Unit Briefing Session

Teijin Limited, Q3 2026 Earnings Call, Feb 04, 2026

Teijin Limited expected to report Fiscal Year 2026 results on May 11, 2026. This event was calculated by S&P Global (Created on February 3, 2026).

Teijin Limited announced that they will report Q3, 2026 results on Feb 04, 2026

Teijin Limited, Board Meeting, Dec 01, 2025. Agenda: To conclude a basic agreement between Teijin Frontier Co., Ltd., a wholly-owned subsidiary of the Company, and Asahi Kasei Advance Corporation, a wholly-owned subsidiary of Asahi Kasei Corporation, to conduct an absorption-type merger, with Teijin Frontier as the surviving company and Asahi Kasei Advance as the absorbed company,, and to make Teijin Frontier a joint venture between the Company and Asahi Kasei after the effective date of the Integration.

Resin & Plastic Processing Business Briefing Session

Teijin Limited announced dividend for the second quarter of fiscal 2025, payable on December 4, 2025. For the quarter, the company reported to pay dividend of JPY 25.00 per share against JPY 25.00 per share a year ago.

Teijin Limited reported an impairment loss for the six months ended September 30, 2025. For the period, the company reported 48.4 billion yen was recorded as an impairment loss on fixed assets of the aramid business. In the aramid business, it is expected to be difficult to achieve the business plan due to the intensifying competition in key applications and the impact of exchange rate fluctuations (the appreciation of the euro) against the backdrop of uncertainty in trade policy of the United States. Since there was an indication of impairment, an impairment test was conducted. As a result, the recoverable amount of fixed assets of the aramid business was determined to be lower than their carrying amount. Therefore, the impairment losses of 41.7 billion yen and 6.7 billion yen were recorded in "Cost of sales" and "Selling, general and administrative expenses," respectively.

Teijin Limited revised consolidated earnings guidance for the year ending March 31, 2026. For the year, the company expects revenue of JPY 860,000 million compared to previous guidance of JPY 860,000 a year ago. Operating income of JPY 5,000 million compared to previous guidance of JPY 20,000 million. Profit attributable to owners of parent of JPY (10,000) million as compared to previous guidance of JPY 12,000 million. Basic earnings per share of JPY JPY (51.85) compared to previous guidance of JPY 62.26. Reasons for revision of earnings forecasts: Considering factors such as the revision of sales volume in the carbon fibers business of the Materials segment and the decrease in profit and loss accounted for the equity method as a result of the conclusion of a share transfer agreement involving the equity-method affiliate in the Others segment,they have revised the adjusted operating income forecast downward from the previous one. The forecasts for operating income, profit attributable to owners of parent and basic earnings per share have also been revised downward from the previous ones, primarily due to the recording of an impairment loss on fixed assets of the aramid business, in addition to the factors behind the revision of the adjusted operating income forecast.

Teijin Limited, ¥ 25.0, Cash Dividend, Mar-30-2026

Teijin Limited expected to report Q3 2026 results on February 6, 2026. This event was calculated by S&P Global (Created on December 10, 2025).

MANAC Chemical Partners Co.,Ltd (TSE:4360) agreed to acquire 99.90% stake in Kinkai Chemicals Co.,Ltd. from Teijin Limited (TSE:3401) on October 30, 2025. As part of acquisition, 164,840 shares will be acquired. For the period ending March 31, 2025, Kinkai Chemicals Co.,Ltd. reported net sales of ¥691 million and operating income of ¥55 million. As of March 31, 2025, Kinkai Chemicals Co.,Ltd. reported total assets of ¥1.15 billion and net assets of ¥863 million. The expected completion of the transaction is March 31, 2026.

Teijin Limited, Q2 2026 Earnings Call, Nov 05, 2025